
Rishi Kundi MD , RPVI, FACS, FSVS (He/Him)
Trauma Surgeon, Vascular Surgeon, Surgical Intensivist at the R Adams Cowley Shock Trauma Center Associate Professor, University of Maryland School of Medicine
Join to view full profile
22 S Greene St# T1R53Baltimore, MD 21201
Phone+1 401-328-9878
Dr. Kundi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- After five years of practice as a vascular surgeon, I returned to fellowship for training in trauma and critical care. I now practice trauma surgery and vascular surgery. I have a clinical and academic focus on vascular injury as well as the use of endovascular and hybrid approaches for both vascular and solid organ injury. I am proud to be a part of the Shock Trauma Center team at University of Maryland Medical Center, the only hospital in the country with a division devoted to vascular and endovascular trauma surgery.
I am also the director of the Go Team, the rapid deployment service of the Shock Trauma Center. In collaboration with the Maryland State Police Aviation Command, we provide surgical and resuscitative intervention to the patient in the field as well as en route critical care.
Before joining the faculty at Shock Trauma, I was part of the Division of Vascular Surgery at Maryland. I took care of patients at the University of Maryland Medical Center and also served the practice at the University's Midtown Campus hospital, the Baltimore VA Medical Center, and the Bon Secours Medical Center, for whom the University provided vascular surgical services until 2020.
Education & Training
George Washington UniversityFellowship, Surgical Critical Care, 2018 - 2019
Columbia University Vagelos College of Physicians and SurgeonsVascular and Endovascular Surgery, 2011 - 2013
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Surgery, 2003 - 2011
Weill Cornell Medical CollegeFellowship, Research Fellowship, Vascular Biology, 2005 - 2008
Michigan State University College of Human MedicineClass of 2003
Certifications & Licensure
MD State Medical License 2013 - 2028
MT State Medical License 2018 - 2028
CO State Medical License 2018 - 2027
DC State Medical License 2018 - 2027
ND State Medical License 2019 - 2027
NY State Medical License 2006 - 2027
American Board of Surgery Surgery
American Board of Surgery Vascular Surgery
American Board of Surgery Surgical Critical Care
Clinical Trials
- Emergency Preservation and Resuscitation (EPR) for Cardiac Arrest From Trauma
- Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma Start of enrollment: 2018 Sep 01
- Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities Start of enrollment: 2015 Aug 18
Publications & Presentations
PubMed
- Blunt Cerebrovascular Injuries (BCVIs): Morphological Insights Into Grade III Injuries.Stephen A Iacono, Eryn Beal, Maggie Sundel, Yvonne Chung, Rishi Kundi
The American Surgeon. 2026-07-28 - 9 citationsThe Society for Vascular Surgery clinical practice guideline on the management of blunt thoracic aortic injury: Focused update.Joseph DuBose, Rishi Kundi, Michael A Curi, Matthew Eagleton, Mark K Eskandari
Journal of Vascular Surgery. 2026-05-01 - 1 citationsUse of High-dose Intravenous Immunoglobulin as Initial Therapy for Heparin-induced Thrombocytopenia in Patients With High Bleeding Risk.Alison V Grazioli, Michael E Plazak, Cynthia S Shen, Thomas M Scalea, Rishi Kundi
Journal of Cardiothoracic and Vascular Anesthesia. 2026-02-01
Press Mentions
Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess™September 15th, 2025
Symvess: Humacyte’s FDA-Approved Bioengineered Solution for Vascular TraumaJanuary 7th, 2025
Humacyte’s Symvess ATEV Approved by FDA for Treatment of Extremity Vascular TraumaDecember 20th, 2024
Grant Support
- Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis PatientsNHLBI2019–2022
- Crgf: Intracellular Mediator During Arterial RemodelingNational Heart, Lung, And Blood Institute2006–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: